Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ
Delayed Data
Oct 16, 2026, 01:30 PM
Day's Range
4.0052 wk Range
4.00Overview - VNDA - Vanda Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
104.93M
P/E (Trailing)
126.00
P/E (Forward)
20.32
PEG Ratio
0.99
Price / Sales (TTM)
1.13
Price / Book
1.11
EV / EBITDA
-0.59
Profitability
Gross Margin
92.95%
Profit Margin
-127.41%
Operating Margin
-126.28%
Return on Assets
-22.37%
Return on Equity
-77.80%
Ownership
Shares Outstanding
60.45M
Float
46.77M
Short % of Shares Outstanding
13.59%
Held by Insiders
6.77%
Held by Institutions
87.53%
Price stats
Beta
0.68
50-Day Avg
4.99
200-Day Avg
6.36
Dividends
Payout Ratio
0.00%
Analyst Consensus
5 analysts
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - VNDA - Vanda Pharmaceuticals Inc.
Peers - VNDA - Vanda Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- VNDANASDAQVanda Pharmaceuticals Inc.242.45MMarket Cap-36.91%52-week change126.00P/E (Trailing)-127.41%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - VNDA - Vanda Pharmaceuticals Inc.
About
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness, inflammatory skin diseases, and gastrointestinal or…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
